Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China
· Delayed Price · Currency is CNY 9.87
-0.12 (-1.20%)
Mar 11, 2026, 3:04 PM CST
SHE:300534 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,030 | 2,639 | 2,994 | 2,691 | 4,465 | 1,756 | Upgrade
|
| Market Cap Growth | 17.39% | -11.85% | 11.27% | -39.74% | 154.23% | -2.69% | Upgrade
|
| Enterprise Value | 3,050 | 2,506 | 2,942 | 2,608 | 4,404 | 1,772 | Upgrade
|
| Last Close Price | 9.99 | 8.67 | 9.78 | 8.79 | 14.58 | 5.74 | Upgrade
|
| PE Ratio | 108.82 | 102.27 | 48.57 | 69.37 | - | 959.17 | Upgrade
|
| PS Ratio | 3.31 | 2.54 | 2.77 | 3.37 | 15.51 | 6.89 | Upgrade
|
| PB Ratio | 4.00 | 3.63 | 4.21 | 3.05 | 6.09 | 2.38 | Upgrade
|
| P/TBV Ratio | 5.05 | 4.51 | 5.37 | 3.57 | 6.81 | 2.67 | Upgrade
|
| P/FCF Ratio | - | 28.71 | - | 11.12 | 88.04 | 70.40 | Upgrade
|
| P/OCF Ratio | - | 15.51 | 31.02 | 10.06 | 87.32 | 40.38 | Upgrade
|
| EV/Sales Ratio | 3.33 | 2.41 | 2.72 | 3.26 | 15.30 | 6.95 | Upgrade
|
| EV/EBITDA Ratio | 23.30 | 18.48 | 26.34 | 31.31 | 332.41 | 101.07 | Upgrade
|
| EV/EBIT Ratio | 34.76 | 25.54 | 35.96 | 46.31 | - | - | Upgrade
|
| EV/FCF Ratio | -16.57 | 27.26 | - | 10.78 | 86.84 | 71.02 | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.15 | 0.20 | - | - | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 1.00 | 0.81 | 1.29 | - | - | 4.00 | Upgrade
|
| Debt / FCF Ratio | - | 1.19 | - | - | - | 2.81 | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.25 | -0.20 | -0.42 | -0.13 | -0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.36 | -1.33 | -1.29 | -4.43 | -7.48 | -2.74 | Upgrade
|
| Net Debt / FCF Ratio | 0.26 | -1.96 | 4.84 | -1.53 | -1.95 | -1.93 | Upgrade
|
| Asset Turnover | 0.68 | 0.76 | 0.81 | 0.75 | 0.34 | 0.30 | Upgrade
|
| Inventory Turnover | 2.67 | 2.71 | 4.22 | 4.83 | 4.02 | 4.23 | Upgrade
|
| Quick Ratio | 1.14 | 1.01 | 1.21 | 1.50 | 3.59 | 2.78 | Upgrade
|
| Current Ratio | 1.60 | 1.30 | 1.48 | 1.79 | 4.52 | 3.22 | Upgrade
|
| Return on Equity (ROE) | 6.31% | 7.21% | 10.52% | 6.02% | -0.86% | 0.44% | Upgrade
|
| Return on Assets (ROA) | 4.07% | 4.48% | 3.85% | 3.29% | -0.69% | -0.15% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.82% | 8.82% | 11.54% | 7.22% | -1.41% | -0.24% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.10% | 11.10% | 9.10% | 6.20% | -1.20% | -0.30% | Upgrade
|
| Earnings Yield | 0.92% | 0.98% | 2.06% | 1.44% | -0.20% | 0.10% | Upgrade
|
| FCF Yield | -6.07% | 3.48% | -1.00% | 9.00% | 1.14% | 1.42% | Upgrade
|
| Dividend Yield | 0.41% | 0.46% | 0.21% | - | - | - | Upgrade
|
| Payout Ratio | 52.64% | 59.27% | 6.19% | 1.28% | - | 272.45% | Upgrade
|
| Buyback Yield / Dilution | 0.10% | 0.05% | -0.05% | 0.10% | 0.54% | -0.56% | Upgrade
|
| Total Shareholder Return | 0.51% | 0.51% | 0.16% | 0.10% | 0.54% | -0.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.